Viewing nowEsomezol Capsule 20 mg (Esomeprazole Strontium Hydrate)
Esomeprazole Strontium Tetrahydrate 24.6mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200713519 · Notified 2007.12.18 · Insurance code 643504310
Treatment and prevention of acid-related disorders (e.g., reflux disease) and ulcers; relief of gastrointestinal symptoms associated with anti-inflammatory analgesics
This medication is used to treat gastroesophageal reflux disease and erosive reflux esophagitis. It also helps with long-term maintenance therapy to prevent relapse in esophagitis patients and to relieve symptoms in gastroesophageal reflux disease patients without esophagitis. It is used as part of a combination therapy with antibiotics for eradicating Helicobacter pylori in patients with duodenal ulcers or peptic ulcers. It treats symptoms of pain or discomfort in the upper gastrointestinal tract related to the administration of non-steroidal anti-inflammatory drugs for a short period and is effective in the treatment and prevention of gastric ulcers in patients continuing to use these analgesics. Additionally, it is used for the treatment of Zollinger-Ellison syndrome and for the prevention and maintenance of rebleeding in gastric or duodenal ulcers. In summary, this medication is widely used for the treatment of various gastrointestinal diseases and symptom relief.
1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. · Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, on-demand administration is not recommended for controlling recurrent symptoms. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg, twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance treatment following intravenous induction to prevent recurrent bleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction to prevent recurrent bleeding from gastric or duodenal ulcers. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, on-demand administration is not recommended for controlling recurrent symptoms. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients No dose adjustment is necessary.
Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes of symptoms may be controlled by administering 20 mg once daily. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be administered to specific patients. Individuals allergic to this drug or its components, or those with allergies to penicillin or macrolide antibiotics, should not take it. Moreover, patients taking certain heart-related medications or antivirals, as well as breastfeeding women, should not use this medication. Caution is needed while taking this drug, as various side effects may occur, such as blood-related issues, allergic reactions, neurological symptoms, gastrointestinal issues, and liver function abnormalities. Rarely, severe skin reactions or muscle problems may occur; any abnormal symptoms should be discussed with healthcare providers immediately. Regular checks are needed during long-term use, particularly if used for over a year, as the risk of fractures may increase, making bone density management important. Additionally, this medication may slightly raise the risk of bacterial infections in the stomach by reducing stomach acid, so if symptoms like diarrhea persist, consultation with a doctor is advised. Interactions with other medications can occur if taken simultaneously; therefore, any currently taken medications should be reported to a healthcare provider or pharmacist. The safety of this medication during pregnancy has not been sufficiently confirmed, so it should be used with caution, and it is recommended to avoid it while breastfeeding. In the event of an overdose, there is no specific antidote, and appropriate treatment should be pursued based on symptoms. This medication should be kept out of reach of children.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucosal-epidermal junction syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel's syndrome, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distention, allergic reaction, back pain, chest pain, substernal chest pain, facial swelling, flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening of depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, worsening of migraine, sleep disorders, tremor, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory dysfunction, loss of taste, gustatory disorders, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that prevents air and moisture from entering and at cool room temperature, between 1 to 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness for a longer time.
A pinkish-colored hard capsule containing white to light brown granules.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Strontium Tetrahydrate 24.6mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Esomeprazole Strontium Tetrahydrate 49.3mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.